Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Emergency Contraceptives “Highly Suitable” For OTC Switch – NEJM Article

This article was originally published in The Tan Sheet

Executive Summary

Nonprescription hormonal emergency contraception is unlikely to be used as a replacement for long-term contraception, Carolyn Westhoff, MD, Columbia University, writes in the Nov. 6 New England Journal of Medicine

You may also be interested in...

Plan B National Pharmacy Access, OTC Availability Weighed By Barr

Pharmacy access to the Plan B emergency contraceptive could be key to realizing the product's potential in the U.S., Barr Labs CEO Bruce Downey commented during a Nov. 6 earnings call

Barr Plans Move To OTC Market With Plan B Emergency Contraceptive

Barr Laboratories will continue to pursue an Rx-to-OTC switch for the emergency contraceptive Plan B following its planned acquisition of the product

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts